Our colleague Emre Guney from STALICLA (a member of REPO4EU) is one of the co-authors of “A needle for Alzheimer’s in a haystack of claims data“. Make sure to check out the full article here.

In the era of big data, looking for insights in large datasets has become the norm — and health data are no exception. Combining systems-biology-driven, endophenotype-based analysis of drug targets with large-scale medical claims data points to sildenafil as a potential treatment opportunity for Alzheimer’s disease





Photo by David Matos on Unsplash